Objective: Genome wide association studies (GWAS) recently identified single nucleotide polymorphisms (SNPs) in Pyruvate dehydrogenase kinase1 (PDK1), to be associated with prostate cancer (PCa) risk. This gene is activated under hypoxic conditions and encodes for mitochondrial enzymes associated with metabolic pathways. GWAS identified two SNPs,rs1530865 (G>C) and rs2357637 (C>A), in the 3'UTR of PDK1, which were predicted to alter miRNA binding to the PDK1 gene. We hypothesised that PDK1 is involved in PCa progression by regulating cellular metabolic pathways under normoxic and/or hypoxic conditions via miRNAs. Methods: PDK1 function in the PCa cells was determined using a knockdown approach and Seahorse Extracellular Flux(XF) Analyser. I...
Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), ...
PURPOSE: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most re...
Purpose: Aberrant expression of microRNAs (miRNAs) has been discovered in prostate cancer progressio...
Objective: Pyruvate dehydrogenase kinase1 (PDK1), is a mitochondrial enzyme associated with metaboli...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Systematic approaches to functionally identify key players in microRNA (miRNA)-target ne...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
MiRNA-associated genetic variants occurring in regulatory regions can affect the efficiency of tra...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
Like other cancer diseases, prostate cancer (PC) is caused by the accumulation of genetic alteration...
PURPOSE:Prostate cancer (PCa) causes a common male urinary system malignant tumour, and the molecula...
PurposeProstate cancer (PCa) causes a common male urinary system malignant tumour, and the molecular...
Background/Aims: MicroRNAs (miRNAs) are a class of small non-coding RNA molecules which play a signi...
AbstractMicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and met...
Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), ...
PURPOSE: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most re...
Purpose: Aberrant expression of microRNAs (miRNAs) has been discovered in prostate cancer progressio...
Objective: Pyruvate dehydrogenase kinase1 (PDK1), is a mitochondrial enzyme associated with metaboli...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Emerging evidence has revealed that genetic variations in microRNA (miRNA) binding sites...
Background: Systematic approaches to functionally identify key players in microRNA (miRNA)-target ne...
Background: Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certai...
MiRNA-associated genetic variants occurring in regulatory regions can affect the efficiency of tra...
Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cance...
Like other cancer diseases, prostate cancer (PC) is caused by the accumulation of genetic alteration...
PURPOSE:Prostate cancer (PCa) causes a common male urinary system malignant tumour, and the molecula...
PurposeProstate cancer (PCa) causes a common male urinary system malignant tumour, and the molecular...
Background/Aims: MicroRNAs (miRNAs) are a class of small non-coding RNA molecules which play a signi...
AbstractMicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and met...
Purpose: Recent evidence indicates that small noncoding RNA molecules, known as microRNAs (miRNAs), ...
PURPOSE: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most re...
Purpose: Aberrant expression of microRNAs (miRNAs) has been discovered in prostate cancer progressio...